[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-335402-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-335402-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","machine-learning-based-model-for-cd4-conventional-t-cell-genes-to-predict-survival-and-immune-responses-in-colorectal-cancer","Machine learning-based model for CD4 + conventional T cell genes to predict survival and immune responses in colorectal cancer","","Colorectal cancer (CRC) is a leading cause of cancer mortality, and prognostic understanding of CD4Tconv cells remains limited. Transcriptomic and clinical data were retrieved from TCGA and GEO, and CD4TGs were identified using single-cell datasets. Univariate Cox regression selected prognostic genes, followed by 101 machine-learning algorithms to build a risk-assessment framework validated by Kaplan-Meier survival, Cox regression, time-dependent ROC, nomograms, and calibration plots. GSEA supported functional interpretation, and the resulting risk score stratified high/low-risk patients with distinct immune infiltration and immune gene activity, offering eight CD4TGs as biomarkers for CRC risk evaluation and therapy response.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/machine-learning-based-model-for-cd4-conventional-t-cell-genes-to-predict-survival-and-immune-responses-in-colorectal-cancer/335402/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/machine-learning-based-model-for-cd4-conventional-t-cell-genes-to-predict-survival-and-immune-responses-in-colorectal-cancer/335402.png","ImageObject",300,407,{"name":42,"@type":43},"River Wang","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-03","2026-09-21",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",9,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"How were CD4Tconv-related genes identified for the model?","Question",{"text":63,"@type":64},"CD4TGs were pinpointed using single-cell datasets, then prognostic genes were isolated by univariate Cox regression based on TCGA and GEO transcriptomic and clinical data.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"What validation methods were used to assess the risk assessment framework?",{"text":68,"@type":64},"Model performance was evaluated with Kaplan-Meier survival analysis, univariate and multivariate Cox regression, time-dependent ROC curves, nomograms, and calibration plots.",{"name":70,"@type":61,"acceptedAnswer":71},"How does the risk score relate to the tumor immune microenvironment in CRC?",{"text":72,"@type":64},"Patients were divided into high- and low-risk subgroups by the median risk score; the high-risk group showed increased immune infiltration and higher activity of immunity-related genes.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},335402,1790501413,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,115,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":112,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":113,"slug":114},8,30,"research-report",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":112,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":4},1099514067438,"https://ap-avatar.wpscdn.com/avatar/100002539ee87300030?x-image-process=image/resize,m_fixed,w_180,h_180&k=1780474512215547542","[www. nature.com/scientificreports](www. nature.com/scientificreports)  \nOPEN  \nMachine learning-based model for CD4 + conventional T cell genes to predict survival and immune responses in colorectal cancer  \nZijing Wang1,3, Zhanyuan Sun1,3, Hengyi Lv1, Wenjun Wu1, Hai Li2 & Tao Jiang2􀀍  \nGlobally, CRC ranks as a principal cause of mortality, with projections indicating a substantial rise in both incidence and mortality by the year 2040. The immunological responses to cancer heavily rely on the function of CD4Tconv. Despite this critical role, prognostic studies on CRC-related CD4Tconv remain insufficient. In this investigation, transcriptomic and clinical data were sourced from TCGA and GEO. Initially, we pinpointed CD4TGs using single-cell datasets. Prognostic genes were then isolated through univariate Cox regression analysis. Building upon this, 101 machine learning algorithms were employed to devise a novel risk assessment framework, which underwent rigorous validation using Kaplan-Meier survival analysis, univariate and multivariate Cox regression, time-dependent ROC curves, nomograms, and calibration plots. Furthermore, GSEA facilitated the examination of these genes’ potential roles. The RS derived from this model was also analyzed for its implications in the TME, and its potential utility in immunotherapy and chemotherapy contexts. A novel prognostic model was developed, utilizing eight CD4TGs that are significantly linked to the outcomes of patients with CRC. This model’s RS showcased remarkable predictive reliability for the overall survival  \nrates ofCRC patients and strongly correlated with malignancy levels. RS serves as an autonomous prognostic indicator, capable of accurately forecasting patient prognoses. Based on the median value of RS, patients were categorized into subgroups of high and low risk. The subgroup with higher risk demonstrated increased immune infiltration and heightened activity of genes associated with immunity. This investigation’s establishment of a CD4TGs risk model introduces novel biomarkers for the clinical evaluation ofCRC risks. These biomarkers may enhance therapeutic approaches and, in turn, elevate the clinical outcomes for patients with CRC by facilitating an integrated treatment strategy.  \nKeywords Colorectal cancer, CD4+ conventional T cells-related genes, Prognosis, Single-cell, Machine learning  \nColorectal cancer (CRC) ranks as the third most prevalent cancer globally and remains a major cause of cancer mortality1. World Health Organization data from 2020 indicate that globally, there were more than 1.9 million new CRC cases and approximately 930,000 fatalities2. Projections suggest that by 2040, these figures will rise to 3.2 million new cases and 1.6 million deaths3. Although advancements in screening practices, such as colonoscopies, have improved early detection, the survival rates for CRC are still hampered by late-stage diagnoses and variability in treatment responses4. Current standard treatments, such as surgical excision, radiotherapy, and chemotherapy, have shown effectiveness in managing early-stage CRC5. However, their utility is lessened in treating advanced or recurrent stages ofthe disease, and they often entail severe side effects that degrade patient quality of life6. For example, while conventional chemotherapy may improve survival for patients with advanced CRC, their five-year survival rate generally remains under 20%7,8. This underscores the imperative need for thorough research into CRC biomarkers and the development of innovative, effective early diagnostic biomarkers to enhance treatment protocols and boost survival outcomes.  \n1First Clinical Medical College, General Hospital of Ningxia Medical University, 804 Shengli Road, Yinchuan 750004, China. 2Department of Anal-Colorectal Surgery, General Hospital of Ningxia Medical University, 804 Shengli Road, Yinchuan 750004, China. 3Zijing Wang and Zhanyuan Sun contributed equally to this work. 􀀍 email: [jty","cbCaihEHBRPhxBbP","https://ap.wps.com/l/cbCaihEHBRPhxBbP","pdf",4589450,15,"English","# Introduction\n# Methods\n## Data sources and CD4Tconv gene identification\n## Prognostic gene selection and model construction\n# Results\n## Risk-score model performance\n## Survival stratification and immune features\n# Discussion","[{\"question\":\"How were CD4Tconv-related genes identified for the model?\",\"answer\":\"CD4TGs were pinpointed using single-cell datasets, then prognostic genes were isolated by univariate Cox regression based on TCGA and GEO transcriptomic and clinical data.\"},{\"question\":\"What validation methods were used to assess the risk assessment framework?\",\"answer\":\"Model performance was evaluated with Kaplan-Meier survival analysis, univariate and multivariate Cox regression, time-dependent ROC curves, nomograms, and calibration plots.\"},{\"question\":\"How does the risk score relate to the tumor immune microenvironment in CRC?\",\"answer\":\"Patients were divided into high- and low-risk subgroups by the median risk score; the high-risk group showed increased immune infiltration and higher activity of immunity-related genes.\"}]","Machine learning-based model for CD4 + conventional T cell genes to predict survival and immune responses in colorectal cancer | PDF",1790010833,38]